TELA Bio to Announce Second Quarter 2026 Financial Results

TELA Bio (NASDAQ: TELA) announced it will release its second quarter 2026 financial results on Monday, August 10, 2026.

Rhea-AI Summary

TELA Bio (NASDAQ: TELA) announced it will release its second quarter 2026 financial results on Monday, August 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET the same day to review the results and provide a corporate update.

Investors must register online to join the call, either a day in advance or at least 15 minutes before the start. A live webcast and subsequent replay will be available through the Events & Presentations page in the investor section of TELA Bio's website.

Argus Jul 21 session 1 alert

+0.04% close to close 0.3x rel. volume Open Argus

Details

News Market Reaction – TELA

$32.72M Market Cap

In the Jul 21 session, TELA gained 0.04%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The tag-specific record shows an average move of -5% across two prior earnings-date announcements. T...

Analysis

The tag-specific record shows an average move of -5% across two prior earnings-date announcements. This notice sets the reporting timetable; the active S-3 resale registration remains a documented risk to monitor.

Key Figures

Reporting period: Second quarter 2026 Results date: August 10, 2026 Conference call time: 4:30 p.m. ET +1 more

Reporting period

Second quarter 2026

Financial results announcement

Results date

August 10, 2026

Scheduled reporting date

Conference call time

4:30 p.m. ET

Results discussion and corporate update

Minimum registration lead time

15 minutes

Before the conference call

Previous Earnings date Reports

2 past events · Latest: Apr 21

Same Type 2 events

1. Apr 21

   earnings date notice

   24h Move

   -2.6%

   Scheduled second-quarter results and a 4:30 p.m. ET conference call.

2. Mar 10

   earnings date notice

   24h Move

   -7.3%

   Scheduled fourth-quarter and full-year results with a 4:30 p.m. ET webcast.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

soft-tissue reconstruction

1 terms

soft-tissue reconstruction medical

"focused on providing innovative soft-tissue reconstruction solutions"

Surgical methods to repair, replace or rebuild damaged soft tissues such as skin, muscle, fat and tendons, often using grafts, tissue flaps, scaffolds or implants. Investors care because these procedures drive demand for medical devices, biologic products and hospital services, affect treatment costs and reimbursement, and are influenced by clinical outcomes and regulatory approvals—similar to how repairing a ripped fabric requires different tools and materials, altering market needs and revenue opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2026 financial results on Monday, August 10, 2026. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Second Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.

About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.

Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.

Investor Contact
Louisa Smith
ir@telabio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TELA Bio (NASDAQ: TELA) report its Q2 2026 earnings?

TELA Bio will report its second quarter 2026 financial results on Monday, August 10, 2026. According to TELA Bio, the release will be followed by a management conference call and webcast that same afternoon to discuss results and provide a corporate update.

What time is TELA Bio's Q2 2026 earnings conference call on August 10, 2026?

TELA Bio’s Q2 2026 earnings conference call is scheduled for 4:30 p.m. ET on August 10, 2026. According to TELA Bio, management will discuss the quarter’s financial results and offer a broader corporate update during this call and webcast.

How can investors access the TELA Bio (TELA) Q2 2026 earnings webcast and replay?

Investors can access the live webcast and replay via the Events & Presentations page in TELA Bio’s investor section. According to TELA Bio, this online access will host both the real-time stream and the on-demand replay of the earnings call.

Is advance registration required for TELA Bio's second quarter 2026 earnings call?

Yes, advance registration is required to listen to TELA Bio’s Q2 2026 conference call. According to TELA Bio, participants should register online either one day before or at minimum 15 minutes prior to the call’s 4:30 p.m. ET start time.

Where is the registration link for TELA Bio's Q2 2026 earnings conference call?

Investors should register for TELA Bio’s Q2 2026 earnings call through the company’s online registration process. According to TELA Bio, access to the webcast and replay is provided via the Events & Presentations page in the investor section of its website.